Cost-analysis of four diagnostic strategies for Pneumocystis carinii pneumonia in HIV-infected subjects
The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed,...
Saved in:
| Published in | The European respiratory journal Vol. 8; no. 9; pp. 1554 - 1558 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Leeds
Eur Respiratory Soc
01.09.1995
Maney European Respiratory Society |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0903-1936 1399-3003 1399-3003 |
| DOI | 10.1183/09031936.95.08091554 |
Cover
| Abstract | The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed, if negative, by bronchoalveolar lavage (BAL); 85 of these patients were able to undergo an exercise test (ET), prior to induced sputum and BAL. The following strategies were analysed: BAL strategy (BAL whenever PCP is suspected); IS strategy (induced sputum followed by BAL if negative); exercise test (ET) strategy, (ET followed by BAL if the results are abnormal); and the ES (exercise sputum) strategy (i.e. BAL only after abnormal ET and negative IS). The cost of each strategy was calculated by taking into account only direct costs; the conditions in which two given strategies would be cost-equivalent were also evaluated. The prevalence of PCP in this population was 31%; IS had 100% specificity and 71% sensitivity, whilst ET had 100% sensitivity and 77% specificity. The costs of BAL, IS, ET and ES strategies were 210,000, 191,940, 140,700 and 112,700 FF, respectively. The ES strategy is, thus, most suitable for our unit. The most economic strategy depends not only on the cost and characteristics of the procedures, but also on the prevalence of PCP in the test population. In conclusion, we developed a model for use by diagnostic centres in choosing the most suitable strategy, on the basis of the local prevalence of PCP. |
|---|---|
| AbstractList | The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed, if negative, by bronchoalveolar lavage (BAL); 85 of these patients were able to undergo an exercise test (ET), prior to induced sputum and BAL. The following strategies were analysed: BAL strategy (BAL whenever PCP is suspected); IS strategy (induced sputum followed by BAL if negative); exercise test (ET) strategy, (ET followed by BAL if the results are abnormal); and the ES (exercise sputum) strategy (i.e. BAL only after abnormal ET and negative IS). The cost of each strategy was calculated by taking into account only direct costs; the conditions in which two given strategies would be cost-equivalent were also evaluated. The prevalence of PCP in this population was 31%; IS had 100% specificity and 71% sensitivity, whilst ET had 100% sensitivity and 77% specificity. The costs of BAL, IS, ET and ES strategies were 210,000, 191,940, 140,700 and 112,700 FF, respectively. The ES strategy is, thus, most suitable for our unit. The most economic strategy depends not only on the cost and characteristics of the procedures, but also on the prevalence of PCP in the test population. In conclusion, we developed a model for use by diagnostic centres in choosing the most suitable strategy, on the basis of the local prevalence of PCP. The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed, if negative, by bronchoalveolar lavage (BAL); 85 of these patients were able to undergo an exercise test (ET), prior to induced sputum and BAL. The following strategies were analysed: BAL strategy (BAL whenever PCP is suspected); IS strategy (induced sputum followed by BAL if negative); exercise test (ET) strategy, (ET followed by BAL if the results are abnormal); and the ES (exercise sputum) strategy (i.e. BAL only after abnormal ET and negative IS). The cost of each strategy was calculated by taking into account only direct costs; the conditions in which two given strategies would be cost-equivalent were also evaluated. The prevalence of PCP in this population was 31%; IS had 100% specificity and 71% sensitivity, whilst ET had 100% sensitivity and 77% specificity. The costs of BAL, IS, ET and ES strategies were 210,000, 191,940, 140,700 and 112,700 FF, respectively. The ES strategy is, thus, most suitable for our unit. The most economic strategy depends not only on the cost and characteristics of the procedures, but also on the prevalence of PCP in the test population. In conclusion, we developed a model for use by diagnostic centres in choosing the most suitable strategy, on the basis of the local prevalence of PCP.The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed, if negative, by bronchoalveolar lavage (BAL); 85 of these patients were able to undergo an exercise test (ET), prior to induced sputum and BAL. The following strategies were analysed: BAL strategy (BAL whenever PCP is suspected); IS strategy (induced sputum followed by BAL if negative); exercise test (ET) strategy, (ET followed by BAL if the results are abnormal); and the ES (exercise sputum) strategy (i.e. BAL only after abnormal ET and negative IS). The cost of each strategy was calculated by taking into account only direct costs; the conditions in which two given strategies would be cost-equivalent were also evaluated. The prevalence of PCP in this population was 31%; IS had 100% specificity and 71% sensitivity, whilst ET had 100% sensitivity and 77% specificity. The costs of BAL, IS, ET and ES strategies were 210,000, 191,940, 140,700 and 112,700 FF, respectively. The ES strategy is, thus, most suitable for our unit. The most economic strategy depends not only on the cost and characteristics of the procedures, but also on the prevalence of PCP in the test population. In conclusion, we developed a model for use by diagnostic centres in choosing the most suitable strategy, on the basis of the local prevalence of PCP. |
| Author | Housset, B Lebeau, B Chouaid, C |
| Author_xml | – sequence: 1 fullname: Chouaid, C – sequence: 2 fullname: Housset, B – sequence: 3 fullname: Lebeau, B |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2891437$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/8575584$$D View this record in MEDLINE/PubMed https://hal.sorbonne-universite.fr/hal-00597491$$DView record in HAL |
| BookMark | eNqNkUFvFCEYhompqdvqP9CEgzbxMCsMMIC3ZlPdJpvoQb0Slvlmy2YWVpix2X8v253WxIueILzP-yXfwwU6CzEAQq8pmVOq2AeiCaOaNXMt5kQRTYXgz9CMMq0rRgg7Q7MjUh2ZF-gi5y0htOGMnqNzJaQQis_QZhHzUNlg-0P2GccOd3FMuPV2E0riHc5DsgNsPOQSJfw1wLiL7lCyjJ1NPniP9w-PwVvsA17e_qh86MAN0OI8rrflll-i553tM7yazkv0_dPNt8WyWn35fLu4XlWOiYZXquXEaV03tlPQ0RZaxqBeSyJBtoI3DbWsbUAx57pa1E4pkDVXdd0AaFEDu0TiNHcMe3u4t31v9snvbDoYSszRm3n0ZrQwj95K7_2pd2f_NKL1Znm9Msc3QoSWXNNftLBXJ3af4s8R8mB2PjvoexsgjtlIKRWRShTwzQSO6x20T3Mn-yV_O-U2O9t3yQbn8xNWK005kwXjJ8ylmHOC7n9X-vhXzfnBDj6G8qO-_1f53eTDb-7ufQKTd0VmWYQaSFtltHngfgMJnsIP |
| CitedBy_id | crossref_primary_10_1586_eri_10_42 crossref_primary_10_1086_368214 crossref_primary_10_1016_j_cmi_2021_08_017 crossref_primary_10_1183_09031936_02_01372002 crossref_primary_10_3390_jof8030222 crossref_primary_10_1128_cmr_00101_22 |
| ContentType | Journal Article |
| Copyright | 1996 INIST-CNRS Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 1996 INIST-CNRS – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 1XC ADTOC UNPAY |
| DOI | 10.1183/09031936.95.08091554 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1399-3003 |
| EndPage | 1558 |
| ExternalDocumentID | 10.1183/09031936.95.08091554 oai:HAL:hal-00597491v1 8575584 2891437 10_1183_09031936_95_08091554 erj8_9_1554 |
| Genre | Journal Article |
| GeographicLocations | France |
| GeographicLocations_xml | – name: France |
| GroupedDBID | - 02 2WC 3O- 53G 55 5GY 5RE 5VS AALRV AAPBV ABFLS ABOCM ABSGY ABYBQ ACPRK ADACO ADBBV ADDZX AENEX AFFNX AJYGW ALMA_UNASSIGNED_HOLDINGS BAWUL CAG CS3 DIK E3Z EBS EJD F5P FH7 GJ GX1 H13 INIJC KQ8 L7B O0- OK1 P2P PQEST PQQKQ R0Z RHF RHI TER WOQ X7M ZA5 ZE2 ZGI ZXP --- .55 .GJ 18M AAFWJ AAYXX AAZMJ ABCQX ABJNI ABSQV ACEMG ACGFO ADMOG ADYFA AFHIN AIZTS BTFSW CITATION F9R TR2 W8F ~02 1OC 31~ 8-1 AADJU ACXQS AFZJQ AJAOE COF IQODW J5H LH4 LW6 CGR CUY CVF ECM EIF NPM 7X8 1XC ADTOC UNPAY |
| ID | FETCH-LOGICAL-c3564-8d40c9926af8ef1ded33e2b707e7d54661a3d6e83ccf252c88e7248226ee952e3 |
| IEDL.DBID | UNPAY |
| ISSN | 0903-1936 1399-3003 |
| IngestDate | Tue Aug 19 22:48:48 EDT 2025 Tue Oct 14 20:26:56 EDT 2025 Thu Sep 04 19:19:31 EDT 2025 Wed Feb 19 01:11:56 EST 2025 Wed Apr 02 07:26:10 EDT 2025 Thu Apr 24 23:08:33 EDT 2025 Wed Oct 01 06:53:09 EDT 2025 Tue Nov 10 20:54:46 EST 2020 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | Human Immunopathology Protozoa Costs Pneumonia Respiratory disease Lung Pneumocystis carinii AIDS Parasitosis Immune deficiency Infection Viral disease Complication Diagnosis Technique Sporozoa Comparative study |
| Language | English |
| License | CC BY 4.0 Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3564-8d40c9926af8ef1ded33e2b707e7d54661a3d6e83ccf252c88e7248226ee952e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://erj.ersjournals.com/content/erj/8/9/1554.full.pdf |
| PMID | 8575584 |
| PQID | 77780785 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | unpaywall_primary_10_1183_09031936_95_08091554 hal_primary_oai_HAL_hal_00597491v1 proquest_miscellaneous_77780785 pubmed_primary_8575584 pascalfrancis_primary_2891437 crossref_primary_10_1183_09031936_95_08091554 crossref_citationtrail_10_1183_09031936_95_08091554 highwire_smallpub1_erj8_9_1554 |
| ProviderPackageCode | RHF RHI CITATION AAYXX |
| PublicationCentury | 1900 |
| PublicationDate | 1995-Sep |
| PublicationDateYYYYMMDD | 1995-09-01 |
| PublicationDate_xml | – month: 09 year: 1995 text: 1995-Sep |
| PublicationDecade | 1990 |
| PublicationPlace | Leeds |
| PublicationPlace_xml | – name: Leeds – name: England |
| PublicationTitle | The European respiratory journal |
| PublicationTitleAlternate | Eur Respir J |
| PublicationYear | 1995 |
| Publisher | Eur Respiratory Soc Maney European Respiratory Society |
| Publisher_xml | – name: Eur Respiratory Soc – name: Maney – name: European Respiratory Society |
| SSID | ssj0016431 |
| Score | 1.5360258 |
| Snippet | The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected... |
| SourceID | unpaywall hal proquest pubmed pascalfrancis crossref highwire |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1554 |
| SubjectTerms | AIDS-Related Opportunistic Infections AIDS-Related Opportunistic Infections - diagnosis Biological and medical sciences Bronchoalveolar Lavage Bronchoalveolar Lavage - economics Bronchoalveolar Lavage - methods Clinical Laboratory Techniques - economics Costs and Cost Analysis Exercise Test Exercise Test - economics Exercise Test - methods France Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Laboratory Techniques and Procedures Life Sciences Medical sciences Pneumonia, Pneumocystis Pneumonia, Pneumocystis - diagnosis Prevalence Respiratory Function Tests Respiratory Function Tests - economics Santé publique et épidémiologie Sensitivity and Specificity Sputum Sputum - microbiology |
| Title | Cost-analysis of four diagnostic strategies for Pneumocystis carinii pneumonia in HIV-infected subjects |
| URI | http://erj.ersjournals.com/cgi/content/abstract/8/9/1554 https://www.ncbi.nlm.nih.gov/pubmed/8575584 https://www.proquest.com/docview/77780785 https://hal.sorbonne-universite.fr/hal-00597491 https://erj.ersjournals.com/content/erj/8/9/1554.full.pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 8 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1399-3003 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0016431 issn: 0903-1936 databaseCode: KQ8 dateStart: 19880101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals at publisher websites customDbUrl: eissn: 1399-3003 dateEnd: 20240505 omitProxy: true ssIdentifier: ssj0016431 issn: 0903-1936 databaseCode: DIK dateStart: 19940101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1399-3003 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0016431 issn: 0903-1936 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZYJ3F54LqJACsW4jVpGie-PFYTU7lsGhJFgxfLiW0odGnVNKDx6zmnuWhDSFxefXwi2f4cf7aPv0PI89gznyF4jZMKNigmDpUVSZhLabkELybxofDxCZ_O0ldn2dmlVF9u_SUC3tN2ZPOvxqBt-AOjbSRHaoRLYISn09HK-h2yyzOg4QOyOzs5nXzYauthvJXapgcEgoN3-zFrn80BgkdoR3OksggIEyqkp1eWpZ3PGBTZCwZjvKSpoMt8k-vid2T0FrlRlytz8d0sFpcWqKM75GPXtCYu5WtUb_Ko-PGL6uN_tf0uud3SVjppcHaPXHPlfXL9uL2Yf0A-HS6rTWhahRO69NSDC7VNIB840WrTiVKAaU1PS1efL4sLsFW0MHiPNKerbWE5N3Re0unL92ETKuYsreocD4yqPTI7evHucBq2ORzCgmU8DaVN40KphBsvnR9bZxlzSS5i4YTNUmAHhlnuJCsKn2RJIaUTSQqshTunssSxfTIol6V7SGg8drFjBiX0eOpSaZgR3HMbW5da7vOAsG4IddEKnGOejYXebnQk093Aa5XpbuADEvZeq0bg4w_1nwE6-qqozj2dvNFYhg95RarG38YBGXbg0dU5QAJAMtYwhlIr3Xzl4Aqk-u_B_hcYrAjI0w5iGuY7XuKY0i3rSgshMEVAFpD9Bnm9K-ZaBToZkKhH4l-16NG_OjwmN5uH_Rhp94QMNuvaHQA12-RDsvP6rRy2U_EnjJgx6g |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELboVuJx4F0RoMVCXJNN4sSP46qiWhCtemBR4WI5sV0WttnVZgMqv56ZzUMtQuJx9Xgi2f4cf7bH3xDyKvbM5whe46SCDYqJQ2VFGhZSWi7Bi0l8KHx8wqez7O1ZfnYl1Zdbf4mA93Qd2f6rMWgb_sBoG8uxGuMSGOHpdLSyfofs8hxo-Ijszk5OJx-32noYb6W26QGB4ODdfsy6Z3OA4DHa0RypPALChArp2bVlaeczBkUOgsEYL2lq6DLf5rr4HRm9Q2411cpcfjeLxZUF6uge-dQ3rY1L-Ro1myIqf_yi-vhfbb9P7na0lU5anD0gN1z1kNw87i7mH5Hzw2W9CU2ncEKXnnpwobYN5AMnWm96UQowrelp5ZqLZXkJtpqWBu-R5nS1Lazmhs4rOn3zIWxDxZyldVPggVH9mMyOXr8_nIZdDoewZDnPQmmzuFQq5cZL5xPrLGMuLUQsnLB5BuzAMMudZGXp0zwtpXQizYC1cOdUnjq2R0bVsnJPCI0TFztmUEKPZy6ThhnBPbexdZnlvggI64dQl53AOebZWOjtRkcy3Q-8VrnuBz4g4eC1agU-_lD_JaBjqIrq3NPJO41l-JBXZCr5lgTkoAePri8AEgCSRMMYSq10-5X9a5Aavgf7X2CwIiAveohpmO94iWMqt2xqLYTAFAF5QPZa5A2umGsV6GRAogGJf9Wip__q8Izcbh_2Y6TdczLarBu3D9RsUxx0k_AnZsgw9Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cost-analysis+of+four+diagnostic+strategies+for+Pneumocystis+carinii+pneumonia+in+HIV-infected+subjects&rft.jtitle=The+European+respiratory+journal&rft.au=Chouaid%2C+C&rft.au=Housset%2C+B&rft.au=Lebeau%2C+B&rft.date=1995-09-01&rft.issn=0903-1936&rft.volume=8&rft.issue=9&rft.spage=1554&rft_id=info:doi/10.1183%2F09031936.95.08091554&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon |